Kestra Private Wealth Services’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$573K Buy
+8,512
New +$567K 0.01% 1161
2025
Q3
– Sell
-2,415
Closed -$211K – 1692
2025
Q2
$211K Sell
2,415
-10,671
-82% -$836K ﹤0.01% 1482
2025
Q1
$894K Buy
13,086
+2,039
+18% +$166K 0.01% 721
2024
Q4
$859K Buy
11,047
+3,574
+48% +$265K 0.01% 699
2024
Q3
$501K Buy
+7,473
New +$614K 0.01% 872
2022
Q2
– Sell
-2,920
Closed -$373K – 936
2022
Q1
$373K Sell
2,920
-248
-8% -$27.1K 0.02% 674
2021
Q4
$425K Sell
3,168
-364
-10% -$52.3K 0.02% 643
2021
Q3
$483K Buy
3,532
+256
+8% +$32.3K 0.03% 544
2021
Q2
$350K Sell
3,276
-18,128
-85% -$1.74M 0.02% 618
2021
Q1
$1.92M Sell
21,404
-1,448
-6% -$136K 0.13% 178
2020
Q4
$2.07M Buy
+22,852
New +$2.04M 0.15% 154

Other funds holding DXCM

Kestra Private Wealth Services's DXCM Position: Q2 2026 in Review

Kestra Private Wealth Services opened a new position in DexCom (DXCM) in Q2 2026: 8,512 shares worth $573K. The stake represents 0.01% of the portfolio and ranks #1161 among its holdings. This is a return to the name: Kestra Private Wealth Services previously reported a position in DXCM as recently as Q2 2025.

Kestra Private Wealth Services first reported a position in DXCM in Q4 2020 and has held it in 11 quarters since. The position peaked at $2.07M in Q4 2020. 976 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Kestra Private Wealth Services held 8,512 shares of DexCom worth $573K as of Q2 2026.
  • DexCom was a new Kestra Private Wealth Services position in Q2 2026.
  • DexCom made up 0.01% of Kestra Private Wealth Services's portfolio in Q2 2026, its #1161 holding.
  • Kestra Private Wealth Services first reported a position in DexCom in Q4 2020 and has held it in 11 quarters since.
  • Kestra Private Wealth Services's DexCom position peaked at $2.07M in Q4 2020.
  • 976 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Kestra Private Wealth Services's 13F filing for Q2 2026, filed 28 Jul 2026.